207 related articles for article (PubMed ID: 31002994)
1. Challenge to Predict Mobilized Peripheral Blood Stem Cells on the Fourth Day of Granulocyte Colony-Stimulating Factor Treatment in Healthy Donors: Predictive Value of Basal CD34
Martino M; Gori M; Moscato T; Naso V; Ferreri A; Provenzano F; Loteta B; Sanguedolce MC; Console G; Dattola A; Pucci G; Gentile M; Morabito A; Recchia AG; Tripepi G; Pitino A
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1586-1591. PubMed ID: 31002994
[TBL] [Abstract][Full Text] [Related]
2. Basal CD34
Martino M; Gori M; Pitino A; Gentile M; Dattola A; Pontari A; Vigna E; Moscato T; Recchia AG; Barilla' S; Tripepi G; Morabito F
Biol Blood Marrow Transplant; 2017 Jul; 23(7):1215-1220. PubMed ID: 28344060
[TBL] [Abstract][Full Text] [Related]
3. Gender, cholinesterase, platelet count and red cell count are main predictors of peripheral blood stem cell mobilization in healthy donors.
Fürst D; Hauber D; Reinhardt P; Schauwecker P; Bunjes D; Schulz A; Mytilineos J; Wiesneth M; Schrezenmeier H; Körper S
Vox Sang; 2019 Apr; 114(3):275-282. PubMed ID: 30873634
[TBL] [Abstract][Full Text] [Related]
4. Factors predicting peripheral blood progenitor cell mobilization in healthy donors in the era of related alternative donors: Experience from a single center.
Bailén R; Pérez-Corral AM; Pascual C; Kwon M; Serrano D; Gayoso J; Balsalobre P; Muñoz C; Díez-Martín JL; Anguita J
J Clin Apher; 2019 Aug; 34(4):373-380. PubMed ID: 30694583
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors.
Suzuya H; Watanabe T; Nakagawa R; Watanabe H; Okamoto Y; Onishi T; Abe T; Kawano Y; Kagami S; Takaue Y
Vox Sang; 2005 Nov; 89(4):229-35. PubMed ID: 16262756
[TBL] [Abstract][Full Text] [Related]
6. The role of donor characteristics and post-granulocyte colony-stimulating factor white blood cell counts in predicting the adverse events and yields of stem cell mobilization.
Chen SH; Yang SH; Chu SC; Su YC; Chang CY; Chiu YW; Kao RH; Li DK; Yang KL; Wang TF
Int J Hematol; 2011 May; 93(5):652-659. PubMed ID: 21509437
[TBL] [Abstract][Full Text] [Related]
7. Feasibility and cost analysis of day 4 granulocyte colony-stimulating factor mobilized peripheral blood progenitor cell collection from HLA-matched sibling donors.
Newell LF; Shoop KM; Knight RJ; Murray SN; Kwock RP; Jacoby CE; Slater S; Allen BE; Ottowa C; Cota B; Appel PL; Cook RJ; Maziarz RT; Meyers G
Cytotherapy; 2019 Jul; 21(7):725-737. PubMed ID: 31085121
[TBL] [Abstract][Full Text] [Related]
8. [Factors impacting yield of CD34(+) cells from healthy donors mobilized with rhG-CSF].
Zhu L; Zhou LK; Xue M; Yan HM; Liu J; Wang ZD; Ding L; Wang HX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1541-5. PubMed ID: 20030943
[TBL] [Abstract][Full Text] [Related]
9. Tempo of hematologic recovery correlates with peripheral blood CD34+ cell level in patients undergoing stem cell mobilization.
Williams O; Demirer T; Lilleby K; Buckner CD; Bensinger WI
J Clin Apher; 1998; 13(1):1-6. PubMed ID: 9590490
[TBL] [Abstract][Full Text] [Related]
10. Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population.
Vasu S; Leitman SF; Tisdale JF; Hsieh MM; Childs RW; Barrett AJ; Fowler DH; Bishop MR; Kang EM; Malech HL; Dunbar CE; Khuu HM; Wesley R; Yau YY; Bolan CD
Blood; 2008 Sep; 112(5):2092-100. PubMed ID: 18523146
[TBL] [Abstract][Full Text] [Related]
11. The use of hematocrit level for predicting the efficiency of peripheral blood CD34(+) cell collection after G-CSF Mobilization in Healthy Donors.
Pornprasertsud N; Niparuck P; Kidkarn R; Puavilai T; Sirachainan N; Pakakasama S; Hongeng S; Jootar S; Ungkanont A
J Clin Apher; 2015 Dec; 30(6):329-34. PubMed ID: 25663039
[TBL] [Abstract][Full Text] [Related]
12. Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells.
Stroncek DF; Clay ME; Petzoldt ML; Smith J; Jaszcz W; Oldham FB; McCullough J
Transfusion; 1996 Jul; 36(7):601-10. PubMed ID: 8701455
[TBL] [Abstract][Full Text] [Related]
13. Myelopoietin, a chimeric agonist of human interleukin 3 and granulocyte colony-stimulating factor receptors, mobilizes CD34+ cells that rapidly engraft lethally x-irradiated nonhuman primates.
MacVittie TJ; Farese AM; Davis TA; Lind LB; McKearn JP
Exp Hematol; 1999 Oct; 27(10):1557-68. PubMed ID: 10517498
[TBL] [Abstract][Full Text] [Related]
14. [Peripheral monocyte counts at first collection of allo-grafts predicts amount of CD34(+) cells in mixture of rhG-CSF primed bone marrow and mobilized peripheral stem cell grafts].
Chang YJ; Zhao XY; Huo MR; Huang XJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):146-50. PubMed ID: 19236767
[TBL] [Abstract][Full Text] [Related]
15. Predictors for successful PBSC collection on the fourth day of G-CSF-induced mobilization in allogeneic stem cell donors.
van Oostrum A; Zwaginga JJ; Croockewit S; Overdevest J; Fechter M; Ruiterkamp B; Brand A; Netelenbos T
J Clin Apher; 2017 Dec; 32(6):397-404. PubMed ID: 28139098
[TBL] [Abstract][Full Text] [Related]
16. Changes in blood counts after the administration of granulocyte-colony-stimulating factor and the collection of peripheral blood stem cells from healthy donors.
Stroncek DF; Clay ME; Smith J; Ilstrup S; Oldham F; McCullough J
Transfusion; 1996 Jul; 36(7):596-600. PubMed ID: 8701454
[TBL] [Abstract][Full Text] [Related]
17. Negative association of donor age with CD34⁺ cell dose in mixture allografts of G-CSF-primed bone marrow and G-CSF-mobilized peripheral blood harvests.
Li Y; Chang Y; Xu L; Zhang X; Huang X
Chin Med J (Engl); 2014; 127(20):3597-601. PubMed ID: 25316236
[TBL] [Abstract][Full Text] [Related]
18. Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte-colony-stimulating factor [G-CSF], G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage [GM]-CSF) on number of colony-forming unit-GM, engraftment, and Day +100 hematopoietic graft function.
Alexander ET; Towery JA; Miller AN; Kramer C; Hogan KR; Squires JE; Stuart RK; Costa LJ
Transfusion; 2011 Sep; 51(9):1995-2000. PubMed ID: 21392017
[TBL] [Abstract][Full Text] [Related]
19. High-versus standard-dose filgrastim (rhG-CSF) for mobilization of peripheral-blood progenitor cells from allogeneic donors and CD34(+) immunoselection.
Engelhardt M; Bertz H; Afting M; Waller CF; Finke J
J Clin Oncol; 1999 Jul; 17(7):2160-72. PubMed ID: 10561272
[TBL] [Abstract][Full Text] [Related]
20. CD34+ cell mobilization for allogeneic progenitor cell transplantation: efficacy of a short course of G-CSF.
de Fabritiis P; Iori AP; Mengarelli A; Gozzer M; Ferrazza G; De Propris MS; Romano A; Arcese W
Transfusion; 2001 Feb; 41(2):190-5. PubMed ID: 11239221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
